Modulating Cognitive and Social Dynamics in ASD: Targeting D2D3 Dopamine Receptors and Regulating Dopamine Transporter Activity Through CRISPR and Organoid Models

Loading experience... Please wait.

Archives
Back to Neurology

Coming soon.

Content being edited.

Excerpt from: Coming Soon by Peter De Ceuster

Mobile detected. For search functionality, PDF printing, or EyeFriendly Mode, please switch to desktop.

Directed Evolution of the BpsA Carrier Protein Domain for Enhanced Activation by Non-Cognate 4'-Phosphopantetheinyl Transferases Implications for ASD Drug Discovery

Unveiling Temporal Dynamics Probing Serotonin and Dopamine Effects on Time Cell Function Through Integrated Approaches

Targeting Toll-like Receptors in Neurodegeneration: The Potential of Engineered Decoy Receptors as Therapeutic Innovations

Utilizing mTOR Inhibitors as Synergistic Modulators in Augmenting Stem Cell Therapy for Autism Spectrum Disorder

Unraveling Pathways: Exploring the Potential of F. prausnitzii A2-165 in ASD Drug Discovery through Gene Co-Expression Analysis and Gut Organoid-Microbe Co-Culture Setup

Harnessing Single-Cell Omics, CRISPR, MSCs, miRNAs, and Valproic Acid Targeting SHANK3 Mutations and Associated Pathways

Unveiling Temporal Dynamics Probing Serotonin and Dopamine Effects on Time Cell Function Through Integrated Approaches